Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo.

MLA

Pirollo, Kathleen F., et al. “Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells in Vitro and in Vivo.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, vol. 14, no. 7, Apr. 2008, pp. 2190–98. EBSCOhost, https://doi.org/10.1158/1078-0432.CCR-07-1951.

APA

Pirollo, K. F., Rait, A., Zhou, Q., Zhang, X., Zhou, J., Kim, C.-S., Benedict, W. F., & Chang, E. H. (2008). Tumor-targeting nanocomplex delivery of novel tumor suppressor RB94 chemosensitizes bladder carcinoma cells in vitro and in vivo. Clinical Cancer Research : An Official Journal of the American Association for Cancer Research, 14(7), 2190–2198. https://doi.org/10.1158/1078-0432.CCR-07-1951

Chicago

Pirollo, Kathleen F, Antonina Rait, Qi Zhou, Xin-qiao Zhang, Jain Zhou, Chang-Soo Kim, William F Benedict, and Esther H Chang. 2008. “Tumor-Targeting Nanocomplex Delivery of Novel Tumor Suppressor RB94 Chemosensitizes Bladder Carcinoma Cells in Vitro and in Vivo.” Clinical Cancer Research : An Official Journal of the American Association for Cancer Research 14 (7): 2190–98. doi:10.1158/1078-0432.CCR-07-1951.